Top PDF The Hemoglobin Level as a Prognostic Factor in Patients with Non-Small Cell Lung Cancer Treated with Gemcitabine and cis-Platinum
The Hemoglobin Level as a Prognostic Factor in Patients with Non-Small Cell Lung Cancer Treated with Gemcitabine and cis-Platinum
... finding in cancer patients. Up to 30% of patients with different types of tumors have been reported to suffer from anemia ...to the disease process itself or to its treatment, ...
4
High-density lipoprotein cholesterol is a favorable prognostic factor and negatively correlated with C-reactive protein level in non-small cell lung carcinoma.
... NSCLC patients with stage I through IV who were undergoing resection of primary cancer at the Sun Yat-sen University Cancer Center, Guangzhou, China, from April 2005 to December 2011 ...
11
Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
... determine the best cut-off value for LMR as a prognostic ...PFS and OS analyses were performed using the Kaplan-Meier method and the log-rank ...MBR and their association ...
13
Albumin and Neutrophil Combined Prognostic Grade as a New Prognostic Factor in Non-Small Cell Lung Cancer: Results from a Large Consecutive Cohort.
... is the first type of immune cell that responds to the site of infection and attack invaders ...However, the inflammatory cells and cytokines found in tumors are more ...
14
The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer.
... by the ethics committees of Austin Health, St Vincent’s Hospital and Weill Cornell Medical Centre hospitals, patients who underwent pre-operative NAC or surgery with or without ACT for pN2 ...
8
BRCA1: a novel prognostic factor in resected non-small-cell lung cancer.
... patients in the validation ...xylene and alcohols, samples were lysed in a tris-chloride, EDTA, sodium dodecyl sulphate (SDS) and proteinase K containing ...extracted with ...
7
THROMBOCYTOSIS AS PROGNOSTIC FACTOR FOR SURVIVAL IN PATIENTS WITH ADVANCED NON SMALL CELL LUNG CANCER TREATED WITH FIRST- LINE CHEMOTHERAPY.
... Lung cancer remains the most common cause of can- cer death worldwide for both men and ...all lung cancer cases ...of patients diagnosed with NSCLC present at ...
5
Concomitant active tuberculosis prolongs survival in non-small cell lung cancer: a study in a tuberculosis-endemic country.
... tumor cell vaccine raised a question of whether and to what extent is the T cell immunity provoked by systemic injection of tumor cell vaccine enriches in the tumor ...
7
Inglês Jornal Brasileiro de Pneumologia complete v42n5 EN
... presented with a mass in the right upper lobe associated with mediastinal lymph node ...enlargement. The radiological proile was consistent with primary lung ...
102
Int. braz j urol. vol.42 número4
... for the adaptive immune system, and are the cellular basis of cancer immunosur- veillance and immunoediting ...indicate the generation of an effective anti-tu- mor cellular ...
7
PDF EN Jornal Brasileiro de Pneumologia 3 1 english
... aim. The use of TMA blocks have shown various advantages compared to that of traditional sections: savings of time and reagents required to perform the reactions; standardization of reactions; ...
2
Epidermal growth factor receptor (EGFR) mutations in lung cancer: preclinical and clinical data
... NSCLCs in patients with European or African ethnicities, 35% of NSCLCs in East Asians, and 50% of NSCLCs in never- smokers are EGFR mutation ...positive. The paucity of ...
11
Clinics vol.67 número5
... growth factor receptor (EGFR) is critically involved in NSCLC pathogenesis and has recently emerged as an important target for molecular ...Two small-molecule EGFR tyrosine kinase inhibitors, ...
6
An Overview: Treatment of Lung Cancer on Researcher Point of View
... ung cancer leads to death including both man & woman .In diagnostic view PET is a quantitative positron imaging technique which is helpful in early diagnosis of lung cancer ...
7
Bioinformatics Analyses of the Role of Vascular Endothelial Growth Factor in Patients with Non-Small Cell Lung Cancer.
... achieved in the management of NSCLC, identification of specific molec- ular criteria is still a challenge to increase response rates ...[14]. In the present study, we analyzed the gene ...
9
Polymorphisms of homologous recombination genes and clinical outcomes of non-small cell lung cancer patients treated with definitive radiotherapy.
... Lung cancer leads all other cancers in both incidence and mortality ...worldwide. Non-small cell lung cancer (NSCLC) accounts for 89% of all lung ...
9
Prognostic value of FGFR gene amplification in patients with different types of cancer: a systematic review and meta-analysis.
... amplification. In situ hybridization techniques are used to measure gene amplification that relies on either fluorescence (FISH) or chromogenic and silver in situ hybridiza- tion (CISH and ...
8
SERPINB3 in the chicken model of ovarian cancer: a prognostic factor for platinum resistance and survival in patients with epithelial ovarian cancer.
... found in various carcinomas that arise in various organs such as stomach, bronchus, gladder, prostate, testis and ovary due to the ubiquitous nature of ...Especially, in ovaries of both ...
10
Braz. J. Pharm. Sci. vol.50 número4
... to platinum-based chemotherapy is a major clinical challenge in cancer treatment, since the cellular response which confers resistance to carboplatin is multifactorial and poorly ...
10
Prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.
... considered. The disease stage of the included patients was not homogeneous: Zhu et ...studied patients with early-stage disease, and Li et ...tumor and normal ...include ...
13
